Biontech Se - American Depositary Shares (BNTX) closed at $85.26 on November 16, 2026, down 0.4% from the previous close, on volume of 939,801 shares (30-day average 1,042,574).
Data as of November 16, 2026.
16-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 5, 2026 | Ratio Call Spread 1 by 2 | 20-Nov-2687.5 : 92.5[2x] C | 1,698 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the largest for 5, 30, 60 and 90 days
BioNTech Buy Rating Maintained at $108 as Pumitamig Drives Long-Term Growth Outlook
TipRanks (Mon, 16-Nov 8:55 PM ET)
Buy MPC, IHG, COST, and sell PEP, BABA, PPL, among other ideas – Oppenheimer
Seeking Alpha News (Mon, 16-Nov 10:11 AM ET)
BioNTech Earnings Call Signals Oncology Momentum Despite Setbacks
TipRanks (Sat, 14-Nov 7:53 PM ET)
BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update
Globe Newswire (Tue, 3-Nov 6:45 AM ET)
Globe Newswire (Mon, 26-Oct 8:53 AM ET)
Market Chameleon (Mon, 26-Oct 3:07 AM ET)
Globe Newswire (Mon, 26-Oct 5:00 AM ET)
Globe Newswire (Sun, 25-Oct 3:30 AM ET)
Globe Newswire (Thu, 22-Oct 6:45 AM ET)
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
Globe Newswire (Tue, 20-Oct 6:45 AM ET)
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Biontech Se - American Depositary Shares trades on the NASDAQ stock market under the symbol BNTX.
As of November 16, 2026, BNTX stock price declined to $85.26 with 939,801 million shares trading.
BNTX has a beta of 1.26, meaning it tends to be more sensitive to market movements. BNTX has a correlation of 0.13 to the broad based SPY ETF.
BNTX has a market cap of $21.56 billion. This is considered a Large Cap stock.
Last quarter Biontech Se - American Depositary Shares reported $1 billion in Revenue and $2.03 earnings per share. This beat revenue expectation by $314 million and exceeded earnings estimates by $1.06.
In the last 3 years, BNTX traded as high as $131.49 and as low as $76.53.
The top ETF exchange traded funds that BNTX belongs to (by Net Assets): FBT, IBB, FNDF, IDNA, SPDW.
BNTX has underperformed the market in the last year with a price return of -17.9% while the SPY ETF gained +11.2%. BNTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.4% and -3.3%, respectively, while the SPY returned -4.6% and -2.1%, respectively.
BNTX support price is $83.83 and resistance is $87.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BNTX shares will trade within this expected range on the day.